Pharma Journalist

Novo Nordisk Launches Oral Ozempic for Type 2 Diabetes

Read more

Australia Approves First FCS Treatment REDEMPLO by Arrowhead

Read more

Gilead Completes $7.8 Billion Arcellx Acquisition Deal

Read more

EU Approves Rhapsido for Chronic Hives Treatment

Read more

Lilly to Acquire Ajax in $2.3 Billion Deal

Read more

Saphnelo Pen Approval Expands Lupus Treatment Access

Read more

BioMarin Completes $4.8 Billion Amicus Acquisition

Read more

Sun Pharma to Acquire Organon in $11.75 Billion Deal

Read more

Leinco, CellCarta Partner to Advance Proteomics in Oncology

Read more

Cipla Wins US Approval for Generic Ventolin Inhaler

Read more